Similar LDL-C Percent Reductions But Fewer Reaching LDL-C Targets in a Real-world PCSK9 Inhibitor Cohort

April 23, 2020

Abstract Real-world LDL-C Reduction in a Nested Cohort of PCSK9 Inhibitor Patients Feolo, DA, Biskupiak, JE Objectives: Proprotein Convertase Subtilisin Kexin Type 9 inhibitors (PCSK9i)…